Position in ARWR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,481,287
+$750,997 QoQ
Shares Held
23,625
+114.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FORA Capital, LLC holds $20,857,761 across 23 Biotechnology names. ARWR ranks #1 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
23,625 | $1,481,287 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
5,732 | $1,480,690 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,218 | $1,479,950 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
53,409 | $1,479,429 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,471 | $1,479,319 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
19,693 | $1,478,747 | |
| 7 | ABVX |
Abivax S.A.
|
13,186 | $1,468,261 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
27,120 | $1,429,766 |
All Filings in ARWR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,481,287 | 23,625 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $730,290 | 11,000 | Shares | Sole | 2026-02-13 | |
| 2021-06-30 | $533,857 | 6,446 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $161,746 | 2,108 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $229,811 | 5,337 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $574,599 | 13,304 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $416,819 | 14,488 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||